Closer to the Patient Means Better Decisions: Wearable Remote Monitoring of Patients with COVID-19 Lung Disease

Wearable Remote Monitoring Of Patients With Covid-19 Lung Disease

Vaccine development against COVID-19 achieved remarkable speed and success, but for patients already living with the disease’s lasting lung effects, key questions remain unanswered. A perspective published in Clinical and Translational Science, authored by Koneksa Health’s Elena Izmailova and Theodore Reiss, argues that the field’s understanding of COVID-19’s functional impact on the lungs still lags behind its understanding of the underlying pathology, and proposes wearable remote monitoring as part of the solution.

What the Authors Propose

• The knowledge gap: While understanding of COVID-19 lung pathology continues to grow, the authors note that its functional impact on patients remains poorly understood, a gap that matters for treatment guidelines and long-term care.
• The need for longitudinal data: The authors call for cohort studies combining longitudinal clinic-based and home-based monitoring, rather than relying on periodic clinic snapshots alone to characterize how lung function changes over time.
• Key respiratory assessments identified: The most informative respiratory system assessments highlighted include pulmonary function testing, oxygen saturation monitoring, and exercise challenge tests, measures that can be captured both in the clinic and remotely.
• From data to decisions: The authors frame the value of this data explicitly in terms of downstream impact: informing both future intervention trials and the treatment guidelines healthcare providers rely on for managing patients with lingering COVID-19 lung effects.

Why “Closer to the Patient” Is the Right Framing

The title captures the paper’s central argument well: better clinical and research decisions about COVID-19’s long-term lung impact depend on getting closer to the patient, literally, through home-based monitoring, not just accumulating more pathology data from a distance. Wearable and remote respiratory monitoring offers a practical way to gather the longitudinal, real-world data needed to inform both clinical trials and everyday treatment guidelines.

This is the same patient-proximate approach Koneksa Health brings to respiratory and pulmonary digital biomarker programs, pairing remote assessments like pulmonary function and oxygen saturation with the same rigor sponsors expect from in-clinic measures.

Reference: Izmailova ES, Reiss TF. Closer to the Patient Means Better Decisions: Wearable Remote Monitoring of Patients with COVID-19 Lung Disease. Clin Transl Sci. 2021;14(6):2091-2094. doi:10.1111/cts.13085. PMID: 34080295.